Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women

European Journal of Cancer Prevention

Volumn 18, Issue 6, 2009, Pages 482-488

  Alves, Carla ^a   Alves, Luís ^a,b   Lunet, Nuno ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b Unidade de Saúde Familiar Santo André de Canidelo   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Cervical cancer; Cervical cytology test; Opportunistic screening; Portugal

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SOCIOECONOMICS; STRUCTURED QUESTIONNAIRE; URBAN AREA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; CERVIX UTERI; COHORT STUDIES; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; PORTUGAL; PREGNANCY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 70349838698     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328330eb47     Document Type: Article

References (31)

1. Adab P, McGhee SM, Yanova J, Wong CM, Hedley AJ (2004). Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening. Med Care 42:600-609.
2. Adams EK, Breen N, Joski PJ (2007). Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer 109 (2 Suppl):348-358.
3. Arbyn M, Antilla A, Jordan J (2008). European guidelines for quality assurance in cervical cancer screening. Luxembourg: Office for Official Publications of the European Communities.
4. Blackwell DL, Martinez ME, Gentleman JF (2008). Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health. Womens Health Issues 18:85-99.
5. Borras JM, Guillen M, Sanchez V, Junca S, Vicente R (1999). Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev 8:427-434.
6. Breitenecker G, Wiener H, Stani J (2000). Cervical cancer screening in Austria. Eur J Cancer 36:2189-2190.
7. Cabeza E, Esteva M, Pujol A, Thomas V, Sanchez-Contador C (2007). Social disparities in breast and cervical cancer preventive practices. Eur J Cancer Prev 16:372-379.
8. Calle EE, Flanders WD, Thun MJ, Martin LM (1993). Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health 83:53-60.
9. Coughlin SS, Leadbetter S, Richards T, Sabatino SA (2008). Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med 66:260-275.
10. Department of Hygiene and Epidemiology-University of Porto Medical School (SHE-FMUP) (2008). The state of the art of cancer control structures in European countries in January 2008. National Coordination for the Oncological Diseases. Lisbon
11. Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide. GLOBOCAN 2002 IARC CancerBase No 5 version 20. 2004.
12. Gordon NP, Rundall TG, Parker L (1998). Type of health care coverage and the likelihood of being screened for cancer. Med Care 36:636-645.
13. Gorin SS, Heck JE (2005). Cancer screening among Latino subgroups in the United States. Prev Med 40:515-526.
14. Hakama M, Coleman MP, Alexe DM, Auvinen A (2008). Cancer screening: evidence and practice in Europe 2008. Eur J Cancer 44:1404-1413.
15. Harlan LC, Bernstein AB, Kessler LG (1991). Cervical cancer screening: who is not screened and why? Am J Public Health 81:885-890.
16. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, et al. (2000). The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 31:261-270.
17. International Agency for Research on Cancer (IARC) (2005). IARC handbooks on cancer prevention: cervix cancer screening. Lyon: World Health Organization.
18. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, et al. (2008). European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 19:342-354.
19. Lucas R, Rocha O, Bastos J, Costa L, Barros H, Lunet N (2009). Pharmacological management of osteoporosis and concomitant calcium supplementation in a Portuguese urban population: the EpiPorto study (2005-2007). Clin Exp Rheumatol 27:47-53.
20. Makuc DM, Freid VM, Parsons PE (1994). Health insurance and cancer screening among women. Adv Data:1-12.
21. Mandelblatt JS, Gold K, O'Malley AS, Taylor K, Cagney K, Hopkins JS, et al. (1999). Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 28:418-425.
22. Matos SL, van den Eynde AMOL (2004). Use of pap tests for cervical cancer screening and factors related with use in Spain. Aten Primaria 33:229-234.
23. Maxwell CJ, Bancej CM, Snider J, Vik SA (2001). Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-1997 National Population Health Survey (NPHS). Can J Public Health 92:127-133.
24. Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249-256.
25. PNS em Foco. Lisbon: Ministry of Health/Office of the High Commissioner for Health. Informative Bulletin number 4. 2009.
26. Ramos E, Lopes C, Barros H (2004). Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol 14:437-441.
27. Sabates R, Feinstein L (2006). The role of education in the uptake of preventative health care: the case of cervical screening in Britain. Soc Sci Med 62:2998-3010.
28. Sambamoorthi U, McAlpine DD (2003). Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. Prev Med 37:475-484.
29. Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, et al. (2000). Cervical cancer screening in France. Eur J Cancer 36: 2215-2220.
30. Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, et al. (2008). Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 19:725-737.
31. Spitzer M (2007). Screening and management of women and girls with human papillomavirus infection. Gynecol Oncol 107 (2 Suppl 1):S14-S28.